Your browser doesn't support javascript.
loading
Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy.
Schetters, Sjoerd T T; Rodriguez, Ernesto; Kruijssen, Laura J W; Crommentuijn, Matheus H W; Boon, Louis; Van den Bossche, Jan; Den Haan, Joke M M; Van Kooyk, Yvette.
Afiliación
  • Schetters STT; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands y.vankooyk@amsterdamumc.nl sjoerds@irc.vib-ugent.be.
  • Rodriguez E; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • Kruijssen LJW; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • Crommentuijn MHW; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • Boon L; Polpharma Biologics, Utrecht, The Netherlands.
  • Van den Bossche J; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • Den Haan JMM; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands.
  • Van Kooyk Y; Molecular Cell Biology and Immunology, Amsterdam Institute for Infection and Immunity, Cancer Center Amsterdam, Amsterdam UMC - Location VUMC, Amsterdam, The Netherlands y.vankooyk@amsterdamumc.nl sjoerds@irc.vib-ugent.be.
J Immunother Cancer ; 8(2)2020 07.
Article en En | MEDLINE | ID: mdl-32690667
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Terapia Combinada / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Células Presentadoras de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Terapia Combinada / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Células Presentadoras de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article